Share on Facebook
Today, the Regulation on Health Technology Assessment (HTA), a deliverable of the EU Pharmaceutical Strategy, has been adopted. The new rules will allow vital and innovative health technologies - such as innovative medicines, certain medical devices, medical equipment and prevention and treatment methods - to be more widely available. The Regulation will also ensure the efficient use of resources, strengthen the quality of HTA across the EU, and save national HTA bodies and industry from duplicating their efforts, reassure business and ensure the long-term sustainability of EU HTA cooperation.
Created: 2022-01-17 12:46:00
Category: Public Health
Cancer
Hybrid event - Ensuring Equal Access to All: Cancer in Women - Europe’s Beating Cancer Pla...
Created: 2022-01-14 12:43:55
Category: Public Health
Funding
2022 EU4Health work programme adopted to invest over €835 million in health
https://ec.e...